Fujian Wanchen Biotechnology Co. Ltd (300972) — Cash Flow-to-Debt Ratio
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow-to-Debt Ratio of 0.48x as of December 2025, meaning its operating cash flow of CN¥3.63 Billion could theoretically repay 0% of its total liabilities (CN¥7.50 Billion) in one year. See Fujian Wanchen Biotechnology Co. Ltd (300972) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fujian Wanchen Biotechnology Co. Ltd Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. For the full cash flow conversion analysis, see 300972 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year debt coverage analysis for Fujian Wanchen Biotechnology Co. Ltd. Check Fujian Wanchen Biotechnology Co. Ltd (300972) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | CN¥3.63 Billion | CN¥7.50 Billion | ▲ +230.7% |
| 2024 | 0.15x | CN¥848.35 Million | CN¥5.79 Billion | ▼ -53.8% |
| 2023 | 0.32x | CN¥1.02 Billion | CN¥3.23 Billion | ▲ +138.0% |
| 2022 | 0.13x | CN¥70.38 Million | CN¥528.79 Million | ▼ -71.7% |
| 2021 | 0.47x | CN¥98.82 Million | CN¥210.47 Million | ▼ -22.5% |
| 2020 | 0.61x | CN¥156.24 Million | CN¥257.94 Million | ▲ +6.2% |
| 2019 | 0.57x | CN¥177.28 Million | CN¥310.81 Million | — |